Evaluation of PRF Efficiency in the Treatment of Infrabony Defects

1. Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approaches to treatperiodontal diseases. Periodontol 2000 2007; 43: 294–315.10.1111/j.1600-0757.2006.00166.x257032117214846Search in Google Scholar

2. Wang ZS, Feng ZH, Wu GF, Bai SZ, Dong Y, Chen FM, et al. The use of platelet–rich fibrin combined with periodontal ligament and jaw bone mesenchymal stem cell sheets for periodontal tissue engineering. Sci Rep. 2016; 6: 28126.10.1038/srep28126491493927324079Search in Google Scholar

3. Kim TH, Kim SH, Sandor GK, Kim YD. Comparison of platelet–rich plasma (PRP), platelet–rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit–skull defect healing. Arch Oral Biol. 2014; 59: 550–10.1016/j.archoralbio.2014.02.00424667430Search in Google Scholar

4. Choukroun J, Adda F, Schoeffler C, Vervelle A. PRF: An opportunity in perio–implantology. Implantodontie. 2001; 42: 55–62.Search in Google Scholar

5. Dohan Ehrenfest DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet–rich fibrin (PRF): A second–generation platelet concentrate. Part III: Leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 51–5.10.1016/j.tripleo.2005.07.01016504851Search in Google Scholar

6. Dohan Ehrenfest DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet–rich fibrin (PRF): A second–generation platelet concentrate. Part II: Platelet–related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 45–50.10.1016/j.tripleo.2005.07.00916504850Search in Google Scholar

7. Desai, C.B., et al.Use of Platelet–Rich Fibrin over Skin Wounds: Modified Secondary Intention Healing. J Cutan Aesthet Surg, 2013. 6(1): p. 35–7.10.4103/0974-2077.110096366317523723604Search in Google Scholar

8. Martinez CE, Smith PC, Palma VA. The influence of platelet–derived products on angiogenesis and tissue repair: A concise update. Front Physiol. 2015; 6: 290.10.3389/fphys.2015.00290461113626539125Search in Google Scholar

9. Pradeep AR, Rao NS, Agarwal E, Bajaj P, Kumari M, Naik SB. Comparative evaluation of autologous platelet–rich fibrin and platelet–rich plasma in the treatment of 3 wall intrabony defects in chronic periodontitis: A randomized controlled clinical trial. J Periodontol. 2012; 83: 1499–1507.10.1902/jop.2012.11070522348695Search in Google Scholar

10. Mathur A, Bains VK, Gupta V, Jhingran R, Singh GP. Evaluation of intrabony defects treated with platelet–rich fibrin or autogenous bone graft: A comparative analysis. Eur J Dent. 2015; 9: 100–8.10.4103/1305-7456.149653431928425713492Search in Google Scholar

11. Gupta SJ, Jhingran R, Gupta V, Bains VK, Madan R, Rizvi I. Efficacy of platelet–rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: A clinical and cone beam computed tomography study. J Int Acad Periodontol. 2014; 16: 86–96.Search in Google Scholar

12. Ajwani H, Shetty S, Gopalakrishnan D, Kathariya R, Kulloli A, Dolas RS, et al. Comparative evaluation of platelet–rich fibrin biomaterial and open flap debridement in the treatment of two and three wall intrabony defects. J Int Oral Health. 2015; 7: 32–7.Search in Google Scholar

13. Dangaria SJ, Ito Y, Walker C, Druzinsky R, Luan X, Diekwisch TG. Extracellular matrix–mediated differentiation of periodontal progenitor cells. Differentiation 2009; 78: 79–90.10.1016/j.diff.2009.03.005274484519433344Search in Google Scholar

14. Peker E, Karaca IR, Yildirim B. Experimental evaluation of the effectiveness of demineralized bone matrix and collagenated heterologous bone grafts used alone or in combination with platelet–rich fibrin on bone healing in sinus floor augmentation. Int J Oral Maxillofac Implants. 2016; 31: e24–31.10.11607/jomi.441427004298Search in Google Scholar

15. Bigham AS, Dehghani SN, Shafiei Z, Nezhad ST. Xenogenic demineralized bone matrix and fresh autogenous cortical bone effects on experimental bone healing: Radiological, histopathological and biomechanical evaluation. J Orthopaed Traumatol. 2008; 9: 73–80.10.1007/s10195-008-0006-6265695719384620Search in Google Scholar

16. Richard J. Miron, Giovanni Zucchelli, Michael A. Pikos, Maurice Salama, Samuel Lee, Vincent Guillemette, Masako Fujioka–Kobayashi, Mark Bishara, Yufeng Zhang, Hom–Lay Wang, Fatiha Chandad, Cleopatra Nacopoulos, Alain Simon-pieri, Alexandre Amir Aalam, Pietro Felice, Gilberto Sammartino, Shahram Ghanaati, Maria A Hernandez, Joseph Choukroun. Use of platelet–rich fibrin inregenerative dentistry: asystematic review.Clin Oral Invest 2017.Search in Google Scholar

17. Marco Del Corso, Alain Vervelle, Alain Simon-pieri, Ryo Jimbo, Francesco Inchingolo, Gilberto Sammartino, David M. Dohan Ehrenfest. Current Knowledge and Perspectives for the Use of Platelet–Rich Plasma (PRP) and Platelet–Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 1: Periodontal and Dentoalveolar Surgery. Current Pharmaceutical Biotechnology, 2012, 13, 1207–1230 1207 1873–431610.2174/13892011280062439121740371Search in Google Scholar

18. Camargo, P.M.; Lekovic, V.; Weinlaender, M.; Vasilic, N.; Madzarevic, M.; Kenney, E.B. A reentry study on the use of bovine porous bone mineral, GTR, and platelet–rich plasma in the regenerative treatment of intrabony defects in humans. Int. J. PeriodonticsRestorative Dent., 2005, 25(1), 49–59.Search in Google Scholar

19. Lekovic, V.; Camargo, P.M.; Weinlaender, M.; Vasilic, N.; Aleksic, Z.; Kenney, E.B. Effectiveness of a combination of plateletrich plasma, bovine porous bone mineral and guided tissue regeneration in the treatment of mandibular grade II molar furcations in humans. J. Clin. Periodontol., 2003, 30(8), 746–751.10.1034/j.1600-051X.2003.00368.x12887344Search in Google Scholar

20. Camargo, P.M.; Lekovic, V.; Weinlaender, M.; Vasilic, N.; Madzarevic, M.; Kenney, E.B. Platelet–rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J. Periodontal Res.,2002, 37(4), 300–306.10.1034/j.1600-0765.2002.01001.x12200975Search in Google Scholar

21. Yu–Chao Chang, Kuo–Chin Wu, Jiing–Huei Zhao. Clinical application of platelet–rich fibrin as the solegrafting material in periodontal intra-bony defects. Journa of Dental Science 2011; 6. 181–182.10.1016/j.jds.2011.05.010Search in Google Scholar

22. Sharma A, Pradeep AR. Treatment of 3–wall intrabony defects in patients with chronic periodontitis with autologous platelet–rich fibrin: a randomized controlled clinical trial.J Periodontol. 2011 Dec; 82(12): 1705–12.10.1902/jop.2011.11007521513477Search in Google Scholar

23. Rosamma Joseph, Arun Raghunatha, Nitin Sharmab. Clinical effectiveness of autologous platelet rich fibrin in the management of infrabony periodontal defects. Singapore Dental Journal 33(2012) 5–12.10.1016/j.sdj.2012.10.00323739317Search in Google Scholar

24. Bajaj P, Pradeep AR, Agarwal E, Rao NS. Comparative evaluation of autologous platelet–rich fibrin and platelet–rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial. J Periodont Res. 2013; 48 (5): 541–676.10.1111/jre.1204023317096Search in Google Scholar

25. Yang LC, Hu SW, Yan M, Yang JJ, Tsou SH, Lin YY. Antimicrobial activity of platelet–rich plasma and other plasma preparations against periodontal pathogens. J Periodontol. 2015; 86: 310–8.10.1902/jop.2014.14037325345340Search in Google Scholar